Estimaciones de analistas de Wall Street para Can-Fite BioPharma Ltd. (CANF): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | 0.46 |
| EV / EBITDA | 0.05 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $169500 | $844746 | $3.8M | $2.0M | $763000 | $853000 | $810000 | $743000 | $674000 | $408212 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $24190 |
| Beneficio Bruto | $169500 | $844746 | $3.8M | $2.0M | $763000 | $853000 | $810000 | $743000 | $674000 | $384022 |
| I+D | $6.1M | $5.3M | $6.1M | $11.0M | $12.0M | $9.8M | $7.8M | $6.0M | $5.8M | $6.7M |
| Generales y Administrativos | $2.7M | $2.9M | $3.2M | $3.1M | $3.0M | $3.8M | $3.1M | $3.0M | $3.0M | $3.7M |
| Gastos Operativos | $8.8M | $8.2M | $9.2M | $14.0M | $14.9M | $13.7M | $10.9M | $8.9M | $8.8M | $10.4M |
| Beneficio Operativo | -$8.6M | -$7.4M | -$5.4M | -$12.0M | -$14.1M | -$12.8M | -$10.1M | -$8.2M | -$8.1M | -$10.0M |
| EBITDA | -$8.7M | -$7.2M | -$6.1M | -$12.0M | -$14.1M | -$12.8M | -$10.1M | -$8.2M | -$8.1M | -$10.0M |
| Gastos por Intereses | $27296 | $1.1M | $1.2M | $427000 | $363000 | $18000 | $77000 | $14000 | $14000 | $14111 |
| Beneficio Antes de Impuestos | -$7.0M | -$5.0M | -$6.6M | -$12.6M | -$14.4M | -$12.6M | -$10.2M | -$7.6M | -$7.9M | -$9.9M |
| Impuestos | $29116 | $29922 | $4000 | $427000 | 0 | -$20000 | $360000 | 0 | 0 | 0 |
| Beneficio Neto | -$6.9M | -$5.0M | -$6.6M | -$12.6M | -$14.4M | -$12.6M | -$10.2M | -$7.6M | -$7.9M | -$9.9M |
| BPA | $-0.60 | $-0.38 | $-0.34 | $-0.30 | $-0.08 | $-0.06 | $-0.03 | $-0.01 | $-0.01 | $-0.08 |
| BPA Diluido | $-0.60 | $-0.38 | $-0.34 | $-0.30 | $-0.08 | $-0.06 | $-0.03 | $-0.01 | $-0.01 | $-0.08 |
| Acciones en Circulación (Diluidas) | $13.8M | $16.3M | $19.5M | $43.0M | $179.2M | $276.5M | $407.9M | $639.2M | $1.09B | $123.6M |
Precio
| Precio | $2.24 |
| Capitalización | $3M |
| Bolsa | AMEX |
| País | IL |
Empresas relacionadas: BDRX · CLDI · CMND · CNSP · GRI · JAGX · KZIA
Explorar sector: Healthcare · Biotechnology
Más secciones de CANF: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones